title: Administration interval and daptomycin toxicity: a case report of rhabdomyolysis.
authors.forename: F
authors.initials: F
authors.lastname: Sbrana
authors.forename: A
authors.initials: A
authors.lastname: Di Paolo
authors.forename: E M
authors.initials: EM
authors.lastname: Pasanisi
authors.forename: E
authors.initials: E
authors.lastname: Tagliaferri
authors.forename: C
authors.initials: C
authors.lastname: Arvia
authors.forename: M
authors.initials: M
authors.lastname: Puntoni
authors.forename: A
authors.initials: A
authors.lastname: Leonildi
authors.forename: F
authors.initials: F
authors.lastname: Bigazzi
authors.forename: R
authors.initials: R
authors.lastname: Danesi
authors.forename: D
authors.initials: D
authors.lastname: Rovai
authors.forename: C
authors.initials: C
authors.lastname: Tascini
authors.forename: F
authors.initials: F
authors.lastname: Menichetti
mesh_terms: D000368:Aged; D000900:Anti-Bacterial Agents / Q000008:administration & dosage* / Q000009:adverse effects*; D017576:Daptomycin / Q000008:administration & dosage* / Q000009:adverse effects*; D004334:Drug Administration Schedule; D013293:Enterococcus faecalis / Q000302:isolation & purification; D005260:Female; D016908:Gram-Positive Bacterial Infections / Q000188:drug therapy; D006801:Humans; D012206:Rhabdomyolysis / Q000139:chemically induced*
chemical_list: D000900:Anti-Bacterial Agents; D017576:Daptomycin